spHeRix.com
About spHeRix.com
Spherix Incorporated was launched in 1967 as a scientific research company. The company now leverages its scientific and technical expertise and experience through its two subsidiaries—Biospherics Incorporated and Spherix Consulting, Inc. Biospherics is currently conducting a Phase 3 clinical trial investigating the use of D-Tagatose, a stereoisomer of fructose already approved as a sugar substitute, as a treatment for glycemic control in patients with Type 2 diabetes.
